Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline
scientific article
Author/s
author: Sagar Lonial, Kenneth C. Anderson, Pieter Sonneveld, Thierry Facon, Paul G. Richardson, Hartmut Goldschmidt, Edward A. Stadtmauer, Donna E Reece, Jesús San Miguel, Dixie-Lee Esseltine, Jean-Luc Harousseau, Jamie D Cavenagh, Joan Bladé, Mario Boccadoro, Patrick Yung Wen
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.